Published in Microb Pathog on March 01, 1997
Chlamydial persistence: beyond the biphasic paradigm. Infect Immun (2004) 2.78
Chlamydia trachomatis persistence in vitro: an overview. J Infect Dis (2010) 1.74
Reactive arthritis or chronic infectious arthritis? Ann Rheum Dis (2002) 1.46
Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. Antimicrob Agents Chemother (2001) 1.43
Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother (2000) 1.35
Chlamydia pneumoniae infection in human monocytes. Infect Immun (1999) 1.28
The role of the P2X₇ receptor in infectious diseases. PLoS Pathog (2011) 1.15
Persistent Chlamydiae and chronic arthritis. Arthritis Res (2001) 1.05
Autophagy restricts Chlamydia trachomatis growth in human macrophages via IFNG-inducible guanylate binding proteins. Autophagy (2012) 1.04
Optimised sample preparation of synovial fluid for detection of Chlamydia trachomatis DNA by polymerase chain reaction. Ann Rheum Dis (1999) 0.95
Survival of Chlamydia muridarum within dendritic cells. Infect Immun (2007) 0.92
Chlamydia trachomatis-infected macrophages induce apoptosis of activated T cells by secretion of tumor necrosis factor-alpha in vitro. Med Microbiol Immunol (2003) 0.90
Optimised sample DNA preparation for detection of Chlamydia trachomatis in synovial tissue by polymerase chain reaction and ligase chain reaction. Ann Rheum Dis (2001) 0.86
Detection of Chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy and flow cytometry techniques. BMC Infect Dis (2006) 0.86
Infection of human monocyte-derived macrophages with Chlamydia trachomatis induces apoptosis of T cells: a potential mechanism for persistent infection. Infect Immun (2000) 0.86
What's in a word: the use, misuse, and abuse of the word "persistence" in Chlamydia biology. Front Cell Infect Microbiol (2014) 0.85
Chlamydia trachomatis infection results in a modest pro-inflammatory cytokine response and a decrease in T cell chemokine secretion in human polarized endocervical epithelial cells. Cytokine (2013) 0.83
Expression of inflammatory host genes in Chlamydia trachomatis-infected human monocytes. Arthritis Res Ther (2007) 0.82
Synovial Chlamydia trachomatis up regulates expression of a panel of genes similar to that transcribed by Mycobacterium tuberculosis during persistent infection. Ann Rheum Dis (2005) 0.82
Differential infection outcome of Chlamydia trachomatis in human blood monocytes and monocyte-derived dendritic cells. BMC Microbiol (2014) 0.81
Amplification of autoimmune disease by infection. Arthritis Res Ther (2005) 0.81
Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts. Med Microbiol Immunol (2011) 0.80
Detection of Chlamydia trachomatis-DNA in synovial fluid: evaluation of the sensitivity of different DNA extraction methods and amplification systems. Arthritis Res Ther (2009) 0.79
Sézary T-cell activating factor is a Chlamydia pneumoniae-associated protein. Clin Diagn Lab Immunol (1999) 0.78
Ultrastructural Analysis of Chlamydia Pneumoniae in the Alzheimer's Brain. Pathogenesis (Amst) (1999) 0.76
Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight? Int J Clin Rheumtol (2011) 0.75
Peptidomic analysis of human peripheral monocytes persistently infected by Chlamydia trachomatis. Med Microbiol Immunol (2007) 0.75
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet (2002) 6.12
Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis (2005) 3.53
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res (2000) 3.03
Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries. Ann Rheum Dis (2004) 2.95
Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis (2006) 2.72
[Rheumatology: Integration into student training--the RISA- Study. Results of a survey exploring the scale of education and training in rheumatology at German universities]. Z Rheumatol (2004) 2.69
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet (2000) 2.63
Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum (2010) 2.52
Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol (1998) 2.50
Yoga-based intervention for carpal tunnel syndrome: a randomized trial. JAMA (1998) 2.50
Is it mandatory to examine synovial fluids promptly after arthrocentesis? Arthritis Rheum (1989) 2.49
Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med (1987) 2.44
Osteoarthritis of the knee: isokinetic quadriceps exercise versus an educational intervention. Arch Phys Med Rehabil (1999) 2.40
[Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire]. Z Rheumatol (1997) 2.34
Acute gouty arthritis is seasonal. J Rheumatol (1998) 2.29
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study. Ann Rheum Dis (2009) 2.29
Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study. Arthritis Rheum (1996) 2.24
Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial. Arthritis Rheum (2003) 2.20
Chlamydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis: results of a prospective study. Arthritis Rheum (2001) 2.20
Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum (1995) 2.16
Calcium apatite crystals in synovial fluid rice bodies. Ann Rheum Dis (2002) 2.14
Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol (1998) 2.14
Synovitis of recent onset. A clinicopathologic study during the first month of disease. Arthritis Rheum (1973) 2.03
Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol (1988) 1.96
Arthritis associated with apatite crystals. Ann Intern Med (1977) 1.92
[Health economics research in the area of chronic polyarthritis]. Z Rheumatol (2002) 1.91
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis (2007) 1.90
Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. Ann Rheum Dis (2006) 1.86
Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum (1996) 1.85
Needle biopsy of the synovial membrane--experience with the Parker-Pearson technic. N Engl J Med (1972) 1.82
Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years. Rheumatology (Oxford) (2005) 1.82
Multicentric reticulohistiocytosis: case report with immunohistochemical analysis and literature review. Arthritis Rheum (2000) 1.80
Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect Immun (1992) 1.77
Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol (2001) 1.76
Ioxaglate-induced light and electron microscopic alterations in the renal proximal tubular epithelium of rats. Invest Radiol (1991) 1.75
Alizarin red S staining as a screening test to detect calcium compounds in synovial fluid. Arthritis Rheum (1983) 1.73
Immunohistochemistry of normal human knee synovium: a quantitative study. Ann Rheum Dis (2004) 1.72
The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients. Ann Rheum Dis (2001) 1.70
Clinical assessment of the 1987 American College of Rheumatology criteria for rheumatoid arthritis. Scand J Rheumatol (1996) 1.70
Acute monoarthritis. N Engl J Med (1993) 1.69
Articular manifestations of systemic lupus erythematosus. Ann Intern Med (1971) 1.69
Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis Rheum (2001) 1.68
Synovial fluid crystals in osteoarthritis. Arthritis Rheum (1985) 1.66
Letter: A scleroderma-like syndrome with fasciitis, myositis, and eosinophilia. Ann Intern Med (1976) 1.65
Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease. Arthritis Rheum (2001) 1.65
Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study. Ann Rheum Dis (2003) 1.64
Joint effusions, chondrocalcinosis and other rheumatic manifestations in hypothyroidism. A clinicopathologic study. Am J Med (1975) 1.61
Reproducibility of synovial fluid analyses. A study among four laboratories. Arthritis Rheum (1986) 1.59
Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources. Ann Rheum Dis (2003) 1.55
Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis. J Rheumatol (1998) 1.55
Molecular detection of bacterial DNA in venereal-associated arthritis. Arthritis Rheum (1996) 1.55
Serum urate during bouts of acute gouty arthritis. J Rheumatol (1997) 1.53
Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Ann Rheum Dis (2004) 1.53
Articular manifestations of hypertrophic pulmonary osteoarthropathy in bronchogenic carcinoma. Arthritis Rheum (1976) 1.52
Letter: Localized hypertrophic osteoarthropathy with abdominal aortic prosthesis and infection. Ann Intern Med (1974) 1.51
Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) (1999) 1.51
Application of ultrashort laser pulses for intrastromal refractive surgery. Graefes Arch Clin Exp Ophthalmol (2000) 1.48
Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease. Ann Intern Med (1982) 1.48
Effect of joint motion on experimental calcium pyrophosphate dihydrate crystal induced arthritis. J Rheumatol (1990) 1.46
Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis (1999) 1.44
Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthritis Rheum (1995) 1.43
Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. Antimicrob Agents Chemother (2001) 1.43
Usefulness of synovial fluid analysis in the evaluation of joint effusions. Use of threshold analysis and likelihood ratios to assess a diagnostic test. Arch Intern Med (1984) 1.43
Juvenile arthritis in Turner's syndrome: a multicenter study. Clin Exp Rheumatol (1998) 1.41
Recurrent reflex sympathetic dystrophy as a manifestation of systemic lupus erythematosus. J Rheumatol (1993) 1.41
Persian Gulf War myalgia syndrome. J Rheumatol (1997) 1.40
Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol (1994) 1.39
Should we treat postvenereal Reiter's syndrome by antibiotics? J Rheumatol (1991) 1.39
[Detection of Borrelia DNA in urine using polymerase chain reaction in rheumatologic laboratory diagnosis of Lyme borreliosis]. Z Rheumatol (1998) 1.39
Pseudoseptic inflammatory knee effusion caused by phagocytosis of sickled erythrocytes after fracture into the knee joint. Arthritis Rheum (1995) 1.39
Staphylococcus aureus in urine and false-positive immunoassay for Chlamydia. Lancet (1992) 1.39
[The internist's differential diagnosis of low back pains]. Dtsch Med Wochenschr (1995) 1.39
Initially unrecognized calcium pyrophosphate dihydrate deposition disease as a cause of fever. Am J Med (1990) 1.38
The microvasculature of the synovial membrane of the monkey: ultrastructural studies. Arthritis Rheum (1969) 1.36
Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum (1996) 1.35
Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother (2000) 1.35
Evaluation of a yoga based regimen for treatment of osteoarthritis of the hands. J Rheumatol (1994) 1.35
Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum (1987) 1.35
Mononuclear cells in human synovial fluid. Identification of lymphoblasts in rheumatoid arthritis. Arthritis Rheum (1976) 1.34
Sequential changes in human polymorphonuclear leukocytes after urate crystal phagocytosis. An electron microscopic study. Arthritis Rheum (1971) 1.31
Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection. Mol Microbiol (2001) 1.30
Chrysotherapy in psoriatic arthritis. Efficacy and toxicity compared to rheumatoid arthritis. Arthritis Rheum (1978) 1.29
Hydroxyapatite deposition disease. Radiology (1980) 1.29
The synovitis of "non-inflammatory" orthopaedic arthropathies: a quantitative histological and immunohistochemical analysis. Ann Rheum Dis (2008) 1.29
Continuing medical education. Changing behavior and improving outcomes. Arthritis Rheum (1985) 1.28
Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis. Arthritis Rheum (1990) 1.28
Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial. Rheumatology (Oxford) (1999) 1.28
Chlamydia and associated arthritis. Curr Opin Rheumatol (2000) 1.25
Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med (1989) 1.23
Arthropathy in sickle-cell disease. Ann Intern Med (1973) 1.23
Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. Osteoarthritis Cartilage (2003) 1.22
How does one assess early rheumatoid arthritis in daily clinical practice? Best Pract Res Clin Rheumatol (2001) 1.22